Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Drug Topics referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Bempedoic Acid, Approved to Treat LDL Cholesterol, Cuts Risk of Major CV Events by 13%,” highlighted findings from the CLEAR Outcomes trial that were presented at the 72nd American College of Cardiology Scientific Sessions together with the World Congress of Cardiology.
Health Equity & Access Weekly Roundup: November 23, 2024
November 23rd 2024Americans are underinsured, even with employer-based health plans; a thorough critique of the lack of representation among Black patients in clinical trials showcases a persistent theme; systemic barriers in cardiology, breast cancer, and patent systems are examined.
Read More
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
November 22nd 2024The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.
Read More